Clinically silent hypersecretion of growth hormone in patients with pituitary tumors.

Hypersecretion of growth hormone (GH) was found in three women aged 25 to 35 years old, with somatotroph adenomas without clinical stigmata of acromegaly. The patients had previously been diagnosed as having nonfunctioning pituitary macroadenomas, with extrasellar extension. Concentrations of GH were elevated preoperatively in all subjects and could not be suppressed during oral glucose tolerance testing. Somatomedin-C concentrations were elevated in two patients. Immunocytochemical studies of surgically obtained tumor tissue demonstrated sparse positive staining for GH in all subjects. Gel-chromatographic analysis of serum and tumor tissue samples demonstrated that the immunoactive GH was authentic GH. On pathological examination, the tumor was cellular in all cases, consisting of partly acidophilic and partly chromophobic cells. Electron microscopic analysis of one tumor showed a cell composition not previously described. These studies further characterize GH hypersecretion in a subset of patients with clinically nonfunctioning pituitary macroadenomas.

[1]  J. Trouillas,et al.  Somatotropic adenoma manifested by galactorrhea without acromegaly. , 1985, The Journal of clinical endocrinology and metabolism.

[2]  S. Asa,et al.  Histological classification of pituitary disease. , 1983, Clinics in endocrinology and metabolism.

[3]  G. Parveen,et al.  Colonic polyps in patients with acromegaly. , 1982, Annals of internal medicine.

[4]  H. Mabuchi,et al.  The incidence and pathogenesis of hyperlipidaemia in 16 consecutive acromegalic patients. , 1982, Acta endocrinologica.

[5]  F. Doyle,et al.  The Acromegaly Syndrome , 1982 .

[6]  S. Bradbury,et al.  Sleep apnoea in acromegaly. , 1980, British medical journal.

[7]  G. Bottazzo,et al.  AN ASSESSMENT OF GLUCOSE INTOLERANCE IN ACROMEGALY AND ITS RESPONSE TO MEDICAL TREATMENT , 1980, Clinical endocrinology.

[8]  D. Appleton,et al.  EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION , 1980, Clinical endocrinology.

[9]  F. Maloof,et al.  Metabolic clearance and production rates of prolactin in man. , 1979, The Journal of clinical investigation.

[10]  R. Furlanetto,et al.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. , 1977, The Journal of clinical investigation.

[11]  J. Bethune,et al.  Acromegaly with normal fasting growth hormone concentrations but abnormal growth hormone regulation. , 1974, Annals of internal medicine.

[12]  W. Roberts,et al.  Acromegaly and cardiovascular disorders. A prospective study. , 1974, Annals of internal medicine.

[13]  R. Randall,et al.  Median neuropathy (carpal-tunnel syndrome) in acromegaly. A sign of endocrine overactivity. , 1973, Annals of internal medicine.

[14]  Y. Touitou,et al.  The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly. , 1972, The New England journal of medicine.

[15]  J. Lyman,et al.  Successful treatment of acromegaly: metabolic and clinical studies in 145 patients. , 1970, The Journal of clinical endocrinology and metabolism.

[16]  P. Cryer,et al.  Regulation of growth hormone secretion in acromegaly. , 1969, The Journal of clinical endocrinology and metabolism.

[17]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[18]  F. Doyle,et al.  The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. , 1982, The Quarterly journal of medicine.

[19]  C. Lowy,et al.  Mortality in acromegaly. , 1970, The Quarterly journal of medicine.

[20]  C. Lowy,et al.  MORTALITY IN ACROMEGALY1 , 1970 .